MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

The treatment of multiple sclerosis (MS) has improved dramatically over the past two decades thanks to the advent of a second generation of immunomodulatory therapies. They have significantly ...

Different people can have different types of MS, and disease progression and symptoms range greatly from person to person. For both reasons, each person’s treatment plan will be different.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

In MS, immune system cells mistakenly attack myelin. With stem cell treatment, doctors use chemotherapy to destroy these existing immune cells. Then, they introduce the new stem cells, which are ...

The National Multiple Sclerosis Society (NMSS) has launched the first national guidelines for the treatment of Multiple ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...